By THE ASSOCIATED PRESS
Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new United States drugs to its highest level in 19 years.
Published: January 5, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1kGIYFj
from WordPress http://ift.tt/1n0UxbY
via Hadi Aboukhater
No comments:
Post a Comment